Phio Pharmaceuticals (PHIO) stock: insider trades, news & valuation
Health Care · Strong buyingShare price and insider trades
Phio Pharmaceuticals insider trading at a glance (Oct 9, 2026): in the past 12 months, 3 insiders bought $40K and 0 sold $0 of PHIO stock on the open market.
Get emailed when insiders cluster-buy stocks like PHIO
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
PHIO insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $59K | 7 | — | 0 |
| Q2 2026 | $10K | 1 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $22K | 4 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 3 Phio Pharmaceuticals Corp. insiders reported open-market purchases totaling $40K, while 0 insiders reported sales totaling $0.
PHIO stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 30SEC | Ronald Todd PlottDirector | Buy | 5,00042,000 held (+14%) | $1.04 | $5K | -5.9% | — |
| Sep 30SEC | Ronald Todd PlottDirector | Buy | 5,00037,000 held (+16%) | $1.03 | $5K | -5.0% | — |
| Sep 25SEC | Patricia A BradfordDirector | Buy | 6,50064,151 held (+11%) | $1.01 | $7K | -3.1% | — |
| Sep 23SEC | Robert J BittermanCEO, Chair | Buy | 2,000364,871 held (+1%) | $1.03 | $2K | -5.0% | — |
| Sep 16SEC | Patricia A BradfordDirector | Buy | 12,00057,651 held (+26%) | $1.03 | $12K | -5.0% | — |
| Aug 20SEC | Ronald Todd PlottDirector | Buy | 15,000new position | $1.14 | $17K | -14.1% | — |
| Aug 19SEC | Robert J BittermanCEO, Chair | Buy | 10,000431,421 held (+2%) | $1.06 | $11K | -7.6% | — |
| Jun 29SEC | Robert J BittermanCEO, Chair | Buy | 10,000421,421 held (+2%) | $0.99 | $10K | -1.1% | — |
| Jan 2SEC | Robert J BittermanCEO, Chair | Buy | 5,000291,421 held (+2%) | $1.03 | $5K | -5.0% | — |
| Dec 29SEC | Robert J BittermanCEO, Chair | Buy | 5,000286,421 held (+2%) | $1.02 | $5K | -4.0% | — |
| Nov 24SEC | Robert J BittermanCEO, Chair | Buy | 5,000281,421 held (+2%) | $1.14 | $6K | -14.1% | — |
| Nov 19SEC | Robert J BittermanCEO, Chair | Buy | 5,000276,421 held (+2%) | $1.27 | $6K | -22.9% | — |
Insiders at Phio Pharmaceuticals Corp.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Robert J BittermanCEO, Chair | $45K | — | Sep 23, 2026 | — |
| Ronald Todd PlottDirector | $27K | — | Sep 30, 2026 | — |
| Patricia A BradfordDirector | $19K | — | Sep 25, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
PHIO stock: common questions
Are Phio Pharmaceuticals Corp. insiders buying PHIO stock?
In the past 12 months, 3 insiders reported open-market purchases of PHIO worth $40K. The latest was Director Ronald Todd Plott bought $5K of PHIO at $1.04.
Are Phio Pharmaceuticals Corp. insiders selling PHIO stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is PHIO's 52-week range?
Over the past year PHIO has traded between $0.86 and $2.36. It last closed at $0.98 on Oct 9, 2026.